Literature DB >> 10567194

Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. National Intervention Cooperative Study in Elderly Hypertensives Study Group.

.   

Abstract

Although diuretics are recommended for the treatment of hypertension, decreased diuretic use and increased calcium antagonist use necessitate a comparison of the efficacy of these drugs in preventing cardiovascular events. Patients >/=60 years of age with systolic blood pressure of 160 to 220 mm Hg and diastolic blood pressure <115 mm Hg were enrolled. Patients were randomly assigned to 20 mg of sustained-release nicardipine hydrochloride twice daily or 2 mg of trichlormethiazide once daily by the double-dummy method and followed up for 5 years. A total of 414 patients were analyzed: 204 in the nicardipine group and 210 in the diuretic group. Blood pressure at entry was 172/94 mm Hg and 173/93 mm Hg, respectively, and decreased to 147/81 mm Hg and 147/79 mm Hg, respectively. Cardiovascular morbidity rates per 1000 persons per year were similar in the nicardipine and diuretic groups (27.8 and 26.8, respectively; P=0.923). The sex- and age-adjusted risk ratio for the nicardipine group was 0.973 (95% confidence interval, 0.514 to 1.839, P=0.932). The calcium antagonist and diuretic groups had a similarly decreased rate of cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567194

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  31 in total

Review 1.  Prospectively designed overviews of recent trials comparing antihypertensive regimens based on different drug classes.

Authors:  N Chapman; B Neal
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

Review 2.  Blood pressure-independent impact of antihypertensive agents on cardiovascular and renal disease.

Authors:  Debasish Banerjee; Barry J Materson
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

3.  [Differentiation and evaluation of calcium antagonists in therapy of arterial hypertension].

Authors:  H Holzgreve
Journal:  Internist (Berl)       Date:  2003-04       Impact factor: 0.743

Review 4.  Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review.

Authors:  Ina U Park; Anne L Taylor
Journal:  Ann Fam Med       Date:  2007 Sep-Oct       Impact factor: 5.166

Review 5.  Use of calcium antagonists in renal patients: therapeutic benefit or medical malpractice?

Authors:  Douglas A Nigbor; Julia B Lewis
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

Review 6.  Dihydropyridine calcium channel blockers and renal disease.

Authors:  Nicolás R Robles; Francesco Fici; Guido Grassi
Journal:  Hypertens Res       Date:  2016-07-14       Impact factor: 3.872

Review 7.  The INSIGHT and NORDIL trials: Are calcium antagonists equivalent to established drug therapies for cardiovascular protection?

Authors:  M C Ruddy
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

Review 8.  Current treatment of patients with hypertension: therapeutic implications of INSIGHT.

Authors:  Stefano Taddei; Lorenzo Ghiadoni; Antonio Salvetti
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  Has the role of calcium channel blockers in treating hypertension finally been defined?

Authors:  George S Chrysant; Steven G Chrysant
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

Review 10.  Methods of Blood Pressure Assessment Used in Milestone Hypertension Trials.

Authors:  Yi Chen; Lei Lei; Ji-Guang Wang
Journal:  Pulse (Basel)       Date:  2018-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.